Page 357 - Programme book for The International Liver Congress 2015, EASL ILC 2015
P. 357
LP24 SAFETY, EFFICACY AND IMPACT ON LIVER FUNCTION
LP25 OF SIMEPREVIR (SMV) IN COMBINATION WITH
DACLATASVIR (DCV) OR SOFOSBUVIR (SOF) IN
PATIENTS WITH SEVERE HEPATITIS C RECURRENCE
AFTER LIVER TRANSPLANTATION (LT): RESULTS FROM
COMPASSIONATE USE IN EUROPE
Maria-Carlota Londoño, Kerstin Hezner, Christophe Moreno,
Paola Carrai, Ubaldo Visco Comadini, Raffaella Lionetti Lionetti,
Vincenza Calvaruso, Ahmed M Elsharkawy, Martina Sterneck,
Ola Weiland, Carlo Torti, Marco Biolato, Xavier Forns*, Spain
ADD-ON PEGINTERFERON ALFA-2A SIGNIFICANTLY
REDUCES HBSAG LEVELS IN HBEAG-NEGATIVE,
GENOTYPE D CHRONIC HEPATITIS B PATIENTS
FULLY SUPPRESSED ON NUCLEOT(S)IDE ANALOGUE
TREATMENT: THE HERMES STUDY
Pietro Lampertico*, Maurizia R. Brunetto, Antonio Craxì, Giovanni B. Gaeta,
Mario Rizzetto, Giulio Palmieri, Massimo Colombo, Italy
LP26 NUCLEIC ACID POLYMERS ARE EFFICIENT IN BLOCKING LATE BREAKER ePOSTERS
LP27 HEPATITIS DELTA VIRUS ENTRY INVITRO
Dominique Poutay, Mirna Sabra, Georges Abou Jaoudé, Isabelle Chemin,
LP28 Christian Trepo, Andrew Vaillant*, Camille Sureau, Canada
ACH-3422, A NOVEL NUCLEOTIDE PRODRUG INHIBITOR
OF HCV NS5B POLYMERASE
Ed Gane*, Christian Schwabe, Catherine Stedman, Frank Weilert,
Katherine Stuart, Wendy Cheng, Joanna Yang, Heather Robison,
James Hui, John Lahey, Robert Sorensen, David Apelian, Robert Hindes,
New Zealand
EFFICACY OF THE ORAL SOFOSBUVIR-BASED
COMBINATIONS IN HCV GENOTYPE 4-MONO-INFECTED
PATIENTS FROM THE FRENCH OBSERVATIONAL COHORT
ANRS CO22 HEPATHER
Hélène Fontaine*, Christophe Hezode, Fabien Zoulim, Didier Samuel,
Marc Bouliere, Georges Haour, Céline Dorival-Mouly, Vincent Leroy,
Victor De Ledinghen, Sandy Lucier, Dominique Larrey, Albert Tran,
Sophie Metivier,Yves Benhamou, Isabelle Hubert-Fouchard,
François Habersetzer, Patrick Marcellin, Philippe Mathurin,
Laurent Alric, Jean-Pierre Bronowicki, Dominique Guyader,
Véronique Loustaud-Ratti, Anne Minello, Ghassan Riachi, Isabelle Rosa,
Mélanie Simony, Alpha Diallo, Fabrice Carrat, Stanislas Pol, France
Vienna, Austria • April 22–26, 2015 357
LP25 OF SIMEPREVIR (SMV) IN COMBINATION WITH
DACLATASVIR (DCV) OR SOFOSBUVIR (SOF) IN
PATIENTS WITH SEVERE HEPATITIS C RECURRENCE
AFTER LIVER TRANSPLANTATION (LT): RESULTS FROM
COMPASSIONATE USE IN EUROPE
Maria-Carlota Londoño, Kerstin Hezner, Christophe Moreno,
Paola Carrai, Ubaldo Visco Comadini, Raffaella Lionetti Lionetti,
Vincenza Calvaruso, Ahmed M Elsharkawy, Martina Sterneck,
Ola Weiland, Carlo Torti, Marco Biolato, Xavier Forns*, Spain
ADD-ON PEGINTERFERON ALFA-2A SIGNIFICANTLY
REDUCES HBSAG LEVELS IN HBEAG-NEGATIVE,
GENOTYPE D CHRONIC HEPATITIS B PATIENTS
FULLY SUPPRESSED ON NUCLEOT(S)IDE ANALOGUE
TREATMENT: THE HERMES STUDY
Pietro Lampertico*, Maurizia R. Brunetto, Antonio Craxì, Giovanni B. Gaeta,
Mario Rizzetto, Giulio Palmieri, Massimo Colombo, Italy
LP26 NUCLEIC ACID POLYMERS ARE EFFICIENT IN BLOCKING LATE BREAKER ePOSTERS
LP27 HEPATITIS DELTA VIRUS ENTRY INVITRO
Dominique Poutay, Mirna Sabra, Georges Abou Jaoudé, Isabelle Chemin,
LP28 Christian Trepo, Andrew Vaillant*, Camille Sureau, Canada
ACH-3422, A NOVEL NUCLEOTIDE PRODRUG INHIBITOR
OF HCV NS5B POLYMERASE
Ed Gane*, Christian Schwabe, Catherine Stedman, Frank Weilert,
Katherine Stuart, Wendy Cheng, Joanna Yang, Heather Robison,
James Hui, John Lahey, Robert Sorensen, David Apelian, Robert Hindes,
New Zealand
EFFICACY OF THE ORAL SOFOSBUVIR-BASED
COMBINATIONS IN HCV GENOTYPE 4-MONO-INFECTED
PATIENTS FROM THE FRENCH OBSERVATIONAL COHORT
ANRS CO22 HEPATHER
Hélène Fontaine*, Christophe Hezode, Fabien Zoulim, Didier Samuel,
Marc Bouliere, Georges Haour, Céline Dorival-Mouly, Vincent Leroy,
Victor De Ledinghen, Sandy Lucier, Dominique Larrey, Albert Tran,
Sophie Metivier,Yves Benhamou, Isabelle Hubert-Fouchard,
François Habersetzer, Patrick Marcellin, Philippe Mathurin,
Laurent Alric, Jean-Pierre Bronowicki, Dominique Guyader,
Véronique Loustaud-Ratti, Anne Minello, Ghassan Riachi, Isabelle Rosa,
Mélanie Simony, Alpha Diallo, Fabrice Carrat, Stanislas Pol, France
Vienna, Austria • April 22–26, 2015 357
